Pando Bioscience
GenAI-driven biological system design for therapeutics
Pando is a synthetic biology company leveraging generative AI and high-throughput experiments to discover, optimize, and design high-value biological molecules and systems. We specialize in improving the activity, stability, and detectability of these molecules and develop protein binders to amplify their performance. Our in-house screening platform swiftly validates AI-designed molecules, aiming to deliver diverse solutions for the biopharma industry, with a current emphasis on reliable protein and enzyme offerings.